Drugs / Intramuscular Islet Autograft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02872571 | Mar 2013 → Apr 2026 overdue | endocrine pancreas disorder | University Hospital, Lille | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intramuscular Islet Autograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02872571 ↗ |
| Modality | Cell therapy | “autologous islets transplanted in the muscle” NCT02872571 ↗ |
| Route | Intramuscular | “intramuscular islet transplantation” NCT02872571 ↗ |